Carson Wealth (CWM LLC)
RXRX icon

Carson Wealth (CWM LLC)’s Recursion Pharmaceuticals RXRX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65.1K Sell
21,203
-4,815
-19% -$18.6K ﹤0.01% 3617
2025
Q4 		$106K Buy
26,018
+11,413
+78% +$56.5K ﹤0.01% 3015
2025
Q3 		$71K Buy
14,605
+2,789
+24% +$14.6K ﹤0.01% 3241
2025
Q2 		$60K Sell
11,816
-12,278
-51% -$60.3K ﹤0.01% 3133
2025
Q1 		$127K Buy
24,094
+14,065
+140% +$103K ﹤0.01% 2232
2024
Q4 		$68K Buy
10,029
+2,246
+29% +$15.1K ﹤0.01% 2572
2024
Q3 		$51K Buy
7,783
+1,538
+25% +$11K ﹤0.01% 2683
2024
Q2 		$47K Buy
6,245
+19
+0.3% +$166 ﹤0.01% 2515
2024
Q1 		$62K Hold
6,226
– – ﹤0.01% 2162
2023
Q4 		$61K Buy
6,226
+42
+0.7% +$299 ﹤0.01% 2055
2023
Q3 		$47K Hold
6,184
– – ﹤0.01% 2107
2023
Q2 		$46K Buy
6,184
+39
+0.6% +$273 ﹤0.01% 2062
2023
Q1 		$41K Buy
6,145
+5,836
+1,889% +$46.3K ﹤0.01% 2020
2022
Q4 		$2K Sell
309
-8,681
-97% -$85.1K ﹤0.01% 3621
2022
Q3 		$96K Buy
8,990
+4,480
+99% +$45.4K ﹤0.01% 1350
2022
Q2 		$37K Buy
+4,510
New +$30.2K ﹤0.01% 1768
2022
Q1 		– Sell
-4,510
Closed -$77K – 3825
2021
Q4 		$77K Buy
+4,510
New +$84.9K ﹤0.01% 1406
2021
Q2 		$1K Buy
+30
New +$888 ﹤0.01% 2844

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Carson Wealth (CWM LLC)'s RXRX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Recursion Pharmaceuticals (RXRX) stake by 19% in Q1 2026, selling an estimated $18.6K and leaving 21,203 shares worth $65.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3617.

Carson Wealth (CWM LLC) first reported a position in RXRX in Q2 2021 and has held it in 18 quarters since. The position peaked at $127K in Q1 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 21,203 shares of Recursion Pharmaceuticals worth $65.1K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 4,815 Recursion Pharmaceuticals shares in Q1 2026, an estimated $18.6K.
  • Recursion Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3617 holding.
  • Carson Wealth (CWM LLC) first reported a position in Recursion Pharmaceuticals in Q2 2021 and has held it in 18 quarters since.
  • Carson Wealth (CWM LLC)'s Recursion Pharmaceuticals position peaked at $127K in Q1 2025.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.